CMMB vs GWW · $22.2M cap vs P/E 27, rev $9.76B
Chemomab Therapeutics Ltd DRC (CMMB) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
CMMB does not have a complete income-statement cache yet.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
CMMB currently screens at market cap $22.2M. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the CMMB and GWW stock pages for the full models.
Not investment advice.